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Objectives. This study sought to evaluate the role of intraaortic 
balloon pump counterpulsation in preventing hemodynamic in- 
stability and promoting a successful outcome during percutane- 
ous transluminal coronary rotational atherectomy in high risk 
patients. 
Background. The application of rotational atherectomy has 
widened to include patients with complex lesions and left ventric- 
ular dysfunction. Although intraaortic balloon pumping has been 
successfully used to provide hemodynamic support during balloon 
angioplasty, its role in high risk rotational atherectomy has not 
yet been defined. 
Methods. In a retrospective review of 159 consecutive high risk 
patients who underwent rotational atherectomy, 28 had an in- 
traaortic balloon pump placed electively before the procedure 
(Group 1) whereas 131 did not (Group 2). 
Results. Group I was older and more likely to have multivessel 
disease and left ventricular dysfunction. Augmented diastolic 
pressure was maintained >90 mm Hg in all Group 1 patients, and 
significant procedure-related hypotension was encountered in 
nine Group 2 patients, requiring an emergency intraaortic balloon 
pump in five. Procedural success was achieved in all 28 patients in 
Group 1 and in 118 in Group 2 (p = 0.07). Slow flow occurred in 
18% and 17% of Group 1 and 2 patients, respectively. Among 
patients with slow flow, non-Q wave myocardial infarction oc- 
curred only in Group 2 (0% vs. 27%). On multivariate analysis, 
elective intraaortic balloon pump placement was the only variable 
to correlate with a successful procedure uncomplicated by hypo- 
tension (p < 0.05). Hospital stay and vascular complications were 
similar in both groups. 
Conclusions. Elective placement of an intraaortic balloon pump 
before coronary rotational atberectomy in selected high risk 
patients promotes both procedural hemodynamic stability and a 
successful outcome. 
(J Am Coil Cardiol 1995;26:1270-5) 
Just as the initial application of percutaneous transluminal 
corona~ angioplasty to low risk lesions widened to include 
those with high risk characteristics (1), so has the introduction 
of percutaneous transluminal coronary rotational atherectomy 
witnessed a parallel increase in the complexity of lesions and 
patients in which revascularization with this device is at- 
tempted (2,3). Although procedural success with the Heart 
Technology Rotablator (Heart Technology, Inc.) has been 
high and complications low (4), predictors of adverse outcome 
have emerged (3,4). In recent studies, modified American 
College of Cardiology/American Heart Association lesion 
score (5,6), increasingly diffuse disease, female gender, right 
coronary artery target lesion and stenosis angulation all corre- 
lated with major ischemic omplications, including non-Q wave 
myocardial infarction (3,4). 
Elective intraaortic balloon pump counterpulsation has 
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been used successfully to provide circulatory support during 
balloon angioplasty in patients at high risk of procedure- 
related morbidity and mortality (7-9). The mechanisms of 
intraaortic balloon pump support during percutaneous revas- 
cularization include a reduction in cardiac afterload (10,11) 
and an increase in coronary blood flow after relief of coronary 
stenosis by balloon angioplasty (12). Although there is now 
broad experience with intraaortic balloon pump-supported 
angioplasty (7-9), to our knowledge its role during coronary 
rotational atherectomy among high risk patients has not been 
reported. 
We performed a retrospective analysis of all rotational 
atherectomy procedures performed at our institution during a 
1-year period. The current study compares baseline, proce- 
dural and outcome results of high risk patients who did and did 
not receive an elective intraaortic balloon pump before rota- 
tional atherectomy. 
Methods  
Patients. Between June 3, 1993 and June 3, 1994, 238 
patients underwent coronary rotational atherectomy at the 
University of California San Diego Medical Center. To study 
the impact of elective placement of an intraaortic balloon 
pump before coronary rotational atherectomy among high risk 
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candidates, we retrospectively reviewed the records and 
cineangiograms of all patients who underwent rotational 
atherectomy during this period. Lesions were evaluated and 
classified by the investigators using the modified American 
College of Cardiology/American Heart Association (ACC/ 
AHA) lesion score (6), and coronary stenoses were measured 
using calipers. Seventy patients with type A or B1 lesions, and 
therefore at low risk, were excluded from our analysis. One 
patient who had presented with acute myocardial infarction 
<24 h before the procedure was also excluded. Angiograms 
were not available for review in three patients. In five patients, 
rotational atherectomy was attempted; however, the lesion 
could not be crossed with a guide wire, and the procedure was 
abandoned. 
The remaining 159 patients formed the current study group. 
In 28 patients, an angiographically driven decision was made 
on the basis of left ventricular function, modified ACC/AHA 
lesion score and amount of myocardium at risk, to electively 
place an intraaortic balloon pump (Group l) before coronary 
intervention. This procedure was performed for severe left 
ventricular dysfunction (ejection fraction ~35%) in nine pa- 
tients; for moderate l ft ventricular dysfunction (ejection frac- 
tion 36% to 40%) before left anterior descending atherectomy 
in two patients; and for a calcified, ostial, protected left main 
coronary artery in one patient. Because of concern about he 
amount of myocardium supplied by the target vessel, an 
intraaortic balloon pump was placed before 13 ostial or 
proximal left anterior descending coronal)' artery (multivessel 
disease in 11, calcification i  9) and 3 left circumflex coronary 
artery (multivessel disease in 2, ostial in i) procedures. Each 
intraaortic balloon pump was placed through a sheath and 
provided one-to-one counterpulsation before coronary inter- 
vention. The remaining 131 patients (Group 2) with type B2 or 
C lesions did not receive an elective intraaortic balloon pump. 
Patients without femoral access for intraaortic balloon place- 
ment were not considered for rotational atherectomy. 
Rotational athereetomy procedure. The technique of rota- 
tional atherectomy has been previously described (2). All 
patients were pretreated with 325 mg of aspirin before coro- 
nary intervention. An 8F sheath was placed in the femoral vein 
and a 9F sheath in the femoral artery- using the modified 
Seldinger technique. A 6F bipolar temporary, pacing catheter 
was placed in the right ventricle for prophylaxis of transient 
bradyarrhythmias for right, left circumflex and proximal eft 
anterior descending coronary procedures. 
In Group 1, a 9.5F intraaortic balloon pump (Datascope 
Corp.) was placed percutaneously through the femoral artery 
and counterpulsation nitiated. The coronary artery was selec- 
tively engaged using a 9F or 10F high flow guiding catheter. 
Heparin (10,000 U) was administered as a bolus, and the 
activated clotting time was maintained at >300 s throughout 
the procedure, using additional boluses of 2,000 to 5,000 U as 
required. 
The lesion was crossed with a 300-cm, 0.009-in. (0.023 cm) 
Type C wire (Heart Technology, Inc.) manipulated into the 
distal aspect of the artery'. The Rotablator burr was then 
advanced over the wire to a position proximal to the target 
stenosis. The burr was then activated, and rotational atherec- 
tomy was performed by slow advancement of the burr into the 
lesion punctuated by slight, brief burr withdrawal simulating a
slow "pecking" motion, with care taken to avoid a decrease in
revolutions per minute >10%. The device was then withdrawn 
and, after intracoronary nitroglycerin administration (100 to 
200 ~g) and angiography to assess the progress of the proce- 
dure, it was exchanged for burrs of increasing size. After 
rotational atherectomy, complementary balloon angioplasty 
was performed at low pressure (2 atm). 
The patient returned to the cardiac intensive care unit 
where an electrocardiogram (ECG) was obtained immediately 
and was repeated after 12 to 18 h. Depending on procedural 
outcome and hemodynamic stability, the intraaortic balloon 
pump was either emoved later the same day or was continued 
overnight. In all cases, the intraaortic balloon pump and 
vascular sheaths were removed when the activated clotting 
time was <200 s. Arterial tamponade was achieved using either 
manual pressure or mechanical compression with the Com- 
pressar (Instromedix) or FemoStop (USCI) devices. 
An intravenous heparin infusion was continued for 48 h, 
keeping partial thromboplastin mes in the 70 to 90-s range. A 
creatine kinase (CK) assay was performed every 8 h for the first 
postprocedural 16h in all patients and, among patients with 
abnormal values, until a peak had occurred. A CK, MB 
fraction (CK-MB) isoenzyme assay was performed for all 
elevated CK values. Intravenous nitroglycerin was replaced 
after 24 h with an oral or cutaneous preparation, and calcium 
antagonists were administered routinely unless contraindi- 
cated. 
Definitions. The following definitions were used: 1) Proce- 
dure-related hypotension. For Group 1, augmented iastolic 
pressure <90 nun Hg; for Group 2, systolic pressure <90 mm Hg. 
2) Non-Q wave myocardial infarction. Elevation of CK levels 
greater than twice the upper limit of normal, with CK-MB 
>5% and without he development of pathologic Q waves on 
the ECG. 3) lschemia on the ECG. New ST segment elevation 
or depression or T wave changes on the immediate postpro- 
cedural ECG. 4) Slowflow. Occurrence of slow or absent distal 
flow (Thrombolysis n Myocardial Infarction [TIMI] trial flow 
grade :~2) without obvious dissection, thrombus or spasm 
(13,14). 5) Procedural success. TIMI flow grade 3, <50% final 
diameter stenosis and no death, emergency coronary artery 
bypass urgery, coronary stenting or myocardial infarction. 6) 
Combined outcome. Procedural success without procedure- 
related hypotension. 
Statistical analyses. Continuous variables are expressed as 
mean value _+ SD. Unpaired Student tests were used to 
compare continuous variables. Where distributions were not 
normal, nonparametric statistics, uch as the Mann-Whitney U 
test were used. Chi-square analyses were used to test differ- 
ences between groups on categoric variables. Multivariate 
analyses were performed using stepwise logistic regression 
analyses using complications and success as outcomes and 
individual preprocedural variables as independent variables. 
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Table 1. Clinical Characteristics of 159 Study Patients 
Group 1: IABP Group 2: No IABP p 
(n = 28) (n = 131) Value 
Age (yr) 72 ± 7 66 ± 11 0.007 
Female gender 7 (25) 30 (23) NS 
Previous MI 16 (57) 59 (45) NS 
CABG 8 (29) 29 (22) NS 
Current smoking 3 (11) 26 (20) NS 
Diabetes mellitus 6 (21) 45 (34) N8 
Hypertension 13 (46) 79 (60) NS 
Hypercholesterolemia 13 (46) 55 (42) NS 
Class III or IV angina 26 (93) 104 (79) NS 
Data presented are mean value z SD or number (%) of patients. CABG 
coronary artery bypass grafting; IABP = intraaortic balloon pump; MI 
myocardial infarction. 
Stepwise logistic regression was performed using Biomedical 
Data Processing (BMDP) logistic regression. A backward 
stepwise selection procedure was used to identify independent 
predictors of success and complications. Analyses were per- 
formed with and without he ACC/AHA classification because 
overlap exists between the score and the individual factors 
comprising the score. Statistical significance was accepted at 
p < 0.05. 
Resu l ts  
Clinical characteristics. Patients who received an elective 
intraaortic balloon pump were older than those who did not 
(Table 1). There were no other significant clinical differences. 
Table 2. Angiographic Characterist ics of 159 Study Patients 
Group 1: Group 2: 
IABP No IABP p 
In - 28) (n = 131) Value 
LVEF (%) 49 + 20 6(I _+ 13 0.0002 
-<35% t) (32) 7 (5) 0.0001 
MVD 26 (93) 88 (67) 0.0062 
Target lesion 
LAD 18 (64) 69 (53) NS 
LCx S (29) 18 (14) NS 
LMCA 2 (7) 5 (4) NS 
RCA 0 (0) 39 (30) 0.001 
Restenosis 5 (18) 38 (29) NS 
Type B2 lesion 24 (86) I10 (84) NS 
Type C lesion 4 114) 21 (16) NS 
Ostial location 8 (29) 17 (13) 0.04 
Calcification 16 (57) 58 (44) NS 
Lesion length (ram) 9 ± 6 12 : 8 NS 
Preprocedural stenosis (%) 69 ± 9 73 - 10 NS 
Reference artery diameter (mm) 3.0 + 0.4 3.0 = 0.4 NS 
Data presented are mean value _+ SD or number (%) of patients. IABP = 
intraaortic balloon pump; LAD = left anterior descending coronary artery; 
LCx = left circumflex coronary artery; LMCA = left main coronary artery: 
LVEF = left ventricular ejection fraction: MVD = multivessel disease; RCA = 
right coronary artery.. 
Table 3. Procedural  Technique 
Group 1: IABP Group 2: No IABP p 
(n = 28) (n = 131) Value 
Initial burr size (mm) 1.6 _+ 0.2 1.6 _+ 0.2 NS 
Final burr size (mm) 2.0 _+ 0.2 2.0 _+ 0.3 NS 
Burring duration (s) 147 _+ 70 150 _+ 75 NS 
Data presented are mean value - SD. IABP = intraaortic balloon pump. 
Angiographic characteristics. Compared with Group 2, 
patients in Group 1 had poorer left ventricular function and a 
greater incidence of severe left ventricular dysfunction. Mul- 
tivessel disease was more frequent in Group 1 (Table 2). Left 
anterior descending coronary lesions represented almost two- 
thirds of the targets in Group 1. No patient undergoing a right 
coronary artery procedure received an elective intraaortic 
balloon pump. The proportion of patients in modified ACC/ 
AHA classes B2 and C was similar in both groups. An elective 
intraaortic balloon pump was more frequently placed when 
coronary lesions were ostial in location. Lesion length did not 
differ between groups. 
Procedural technique. Initial and final burr sizes, number 
of burrs used and total burring duration were not different 
between groups (Table 3). Two patients (7%) in Group 1 
underwent a second interventional procedure immediately 
after the rotational atherectomy (diagonal angioplasty in one, 
obtuse marginal angioplasty in one). In Group 2, nine patients 
(7%) had a second intervention (diagonal angioplasty in four, 
obtuse marginal angioplasty in two, right coronary angioplasty 
in one, saphenous vein graft angioplasty in one, saphenous vein 
graft stent in one). 
Procedural Success and Complications. Coronary rot'a- 
tional atherectomy was successfully performed in all 28 pa- 
tients in Group 1 (Table 4). There were 13 unsuccessful 
procedures in Group 2. Five patients had TIMI flow grade _<2 
at the conclusion of the procedure. Non-Q wave myocardial 
infarction occurred in four of these five patients (80%), and 
Table 4. Procedural  Outcome and Complicat ions 
Group 1: IABP Group 2: No IABP p 
(n = 28) (n = 131) Value 
Procedural success 100 (81,100) 90 (85, 95) 0.07 
Emergency CABG 0 (0, 0) 1 (0, 1) NS 
Death 0 (0, 0) 2 (0, 4) NS 
Non-Q wave MI l) (0, 0) 7 (0, 14) NS 
Combined 0 (0, 0) 13 (10, 16) 0.04 
outcome 
Slow flov, 18 (4, 22) 17 (11, 23) NS 
Dissection 18 (4, 22) 19 (12, 26) NS 
ECG ischemia 7 (0, 16) 13 (7, 19) NS 
Total CK 90 _+ 58 96 _+ 73* 0.0001 
(IUqiter) 588 _+ 2187 
*Absence of non-Q wave myocardial infarction (MI) (n = 122). ?Presence of 
non-Q wave myocardial infarction (n = 9). Data presented are mean -- SD or 
percent of patients (95% confidence limits). CK = creatine kinase; ECG = 
electrocardiographic: other abbreviations as in Table 1. 
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Table 5. Rates of Non-Q Wave Myocardial Infarction Among 
Patients Who Developed Slow Flow 
Slow Flow Non-Q Wave MI 
(no. of pts) [no. (%) of pts] 
IABP (Group 1) 5 0 (0%) 
No IABP (Group 2) 22 6 (27%} 
pts = patients; other abbreviations as in Table 1. 
one developed refractory ventricular fibrillation 14 h after the 
procedure and died. An additional five patients ustained a
non-Q wave myocardial infarction. One patient had an exten- 
sive flow-limiting dissection with TIMI flow grade l, requiring 
three 3.0-mm Wiktor stents with restoration of TIMI flow 
grade 3 and minimal residual stenosis. In one patient, with a 
chronic total occlusion at the ostium of the right coronary 
artery followed by a long diffusely diseased segment, he final 
residual stenosis was >50%. After atherectomy with a 
1.75-ram burr in the mid-left anterior descending coronary 
artery, one patient developed chest pain, supraventricular 
arrhythmia and hypotension. An intraaortic balloon pump was 
immediately placed, and fluid and inotropic support led to 
transient stabilization. However, on transfer to the cardiac 
intensive care unit, severe limb ischemia due to the intraaortic 
balloon pump mandated its removal. The patient rapidly 
became hemodynamically unstable and was taken to the 
operating room for emergency b pass urgery. Despite success- 
ful grafting of the left anterior descending coronary artery, the 
patient could not be weaned from bypass because of severe 
ischemic left ventricular dysfunction and died in the operating 
room. 
Procedure.related hypotension. Although systolic pressure 
decreased to<90 mm Hg in three patients (11%) in Group 1, 
diastolic pressure, augmented byan electively placed intraaor- 
tic balloon pump, was maintained at>90 mm Hg at all times. 
Hypotension occurred in nine patients (7%) in Group 2, 
requiring emergency placement ofan intraaortic balloon pump 
for persistent hypotension a d hemodynamic instability in five. 
Arrhythnlia. Transient atrial fibrillation developed in three 
patients (2%) in Group 2, resolving in all patients within 6 to 
12 h of the procedure. Two patients developed ventricutar 
fibrillation after transfer to the cardiac intensive care unit. In 
one patient it occurred within 30 min, and the patient re- 
sponded to resuscitation. In the second patient, ventricular 
fibrillation occurred 14 h after the procedure and was refrac- 
tory to all measures, and the patient died. 
Impact of intraaortic balloon pump on non-Q wave myo- 
cardial infarction after slow flow. Although slow flow oc- 
curred with equal frequency in both groups, no patient in 
Group 1 who developed slow flow went on to sustain a non-Q 
wave myocardial infarction (Table 5). In contrast, 6 (27%) of 
22 Group 2 patients who had slow flow developed a non-Q 
wave myocardial infarction within 24 h of rotational atherec- 
tomy; in 3 of 6, non-Q wave myocardial infarction occurred 
despite emergency placement of an intraaortic balloon pump. 
One patient from Group 1 with multivessel coronary dis- 
Table 6. Logistic Regression Analysis of Combined Outcome 
P 
Variable Coeff SE Value 
Prophylactic 1ABP 8.311 2.36 0.0454 
Gender 1.9023 0.59 0.1411 
Age 4.0054 1.56 0.0986 
Previous MI 0.2920 0.58 0.6590 
Angina class 0.6124 0.46 0.3350 
Diabetes -0.5085 0.58 0.3184 
LVEF 0.1878 0.58 0.6647 
1- vs. 2- and 3-vessel disease 0.3735 0.56 0.7256 
Vessel treated 0.2565 0.67 0.5705 
Lesion length 0.0184 0.80 0.8922 
New lesion vs. restenosis 0.6124 0.70 0.4098 
Ostial lesion 0.8446 1.10 0.2727 
Bend lesion 0.2527 0.67 0.7241 
Calcification -0.9006 0.58 0.1393 
Coell = coefficient; other abbreviations a in Tables 1 and 2. 
ease developed chest pain 48 h after successful left anterior 
descending rotational atherectomy. Coronary angiography re- 
vealed a patent left anterior descending coronary artery and a 
diffusely diseased right coronary artery with reduced flow, and 
the patient went on to sustain a non-Q wave myocardial 
infarction. Q wave myocardial infarction did not occur in either 
group. 
Dissection, perforation and ECG changes. Dissection was 
seen with similar frequency in both groups but was flow 
limiting in only one Group 2 patient (Table 4). Coronary 
perforation manifested by extravasation of contrast medium 
with persistent s aining was present in three patients (2%) in 
Group 2. Electrocardiographic evidence of ischemia was 
present in 7% and 13% of Group 1 and 2 patients, respectively. 
Assessment of impact of intraaortic balloon pump. To 
evaluate the role of elective placement of an intraaortic 
balloon pump in high risk patients, we used our definitions to 
calculate an end point combining procedure-related hypoten- 
sion and an unsuccessful procedure (Tables 4 and 6). Patients 
in Group 1 had a significantly better combined outcome than 
those in Group 2 (0 [0%] vs. 17 [13%], respectively p = 0.04). 
By multivariate logistic regression, the only variable found to 
be predictive of a successful procedure without procedure- 
related hypotension was the prophylactic placement of an 
intraaortic balloon pump (p < 0.05). 
Hemorrhagic and vascular complications. Group i. One 
patient developed a pseudoaneurysm that was surgically re- 
paired. A second patient experienced a groin hemorrhage and 
required ablood transfusion. A third patient developed a large 
arm hematoma after brachial cutdown and required a transfu- 
sion. However, there was no bleeding at the intraaortic balloon 
pump access ite in the groin. 
Group 2. One patient developed a large groin hematoma 
that required surgical repair and blood transfusion. One 
patient, described earlier, had acute limb ischemia forcing 
immediate intraaortic balloon pump removal. 
1274 O'MURCHU ET AL. JACC Vol. 26, No. 5 
IABP IN HIGH RISK ROTATIONAL ATHERECTOMY November 1, 1995:1270-5 
Duration of hospital stay. Mean hospital stay was 2.6 + 1.3 
days for Group 1 and 2.4 _+ 1.1 days for Group 2 (p : 0.40). 
Discuss ion  
The current study reports our experience with elective 
intraaortic balloon pump counterpulsation during high risk 
coronary rotational atherectomy. Although intraaortic balloon 
pump--supported rotational therectomy has been described in 
a small number of high risk patients (2) the outcome of this 
strategy has not specifically been reported. We demonstrated 
that this strategy can facilitate a successful and uncomplicated 
procedural outcome in high risk patients undergoing rotational 
atherectomy. 
High risk patient characteristics and selection for intraaor- 
tic balloon pump. Recent compelling data from Ellis et al. (4) 
and Warth et al. (15) have shown a correlation between 
modified ACC/AHA lesion criteria and major ischemic om- 
plications during rotational atherectomy, occurring with a 
frequency of 4.1%, 5%, 8.4% and 26.1% in type A, B1, B2 and 
C lesions, respectively. In the present study, patients who 
received a prophylactic intraaortic balloon pump were com- 
pared with those at higher isk for percutaneous revasculariza- 
tion on the basis of modified ACC/AHA lesion criteria. The 
"higher-risk" group was arbitrarily defined as patients with 
type B2 or C lesions and included some patients with left 
ventricular dysfunction. Patients with type A and B1 lesions 
undergoing rotational atherectomy have success and compli- 
cation rates unlikely to be favorably influenced by elective 
intraaortic balloon pump placement (4); these patients were 
not included in the current report. The group receiving an 
elective intraaortic balloon pump was older, had more severe 
left ventricular dysfunction and was more likely to have 
multivessel disease and an ostial lesion than did the compari- 
son group. No patient with a right coronary stenosis was 
treated with a prophylactic intraaortic balloon pump. 
The decision to electively place an intraaortic balloon pump 
was individualized and based on the patient's angiographic 
profile. The chief indications were significant left ventricular 
dysfunction and ostial or proximal stenosis, often with severe 
calcification and multivessel disease, in the left anterior de- 
scending or, less frequently, the left circumflex coronary artery. 
In the latter patients, there was clinical concern that significant 
distal embolization of athercctomized particles could result in 
hemodynamic instability. 
Procedural success. Previous studies (2,4) have reported 
overall success rates for rotational atherectomy of 90% to 
94%. However, neither of these studies specifically report 
procedural results for the minority of patients who received a 
prophylactic intraaortic balloon pump. In the present study, 
procedural success was achieved in 100% of patients with and 
in only 90% of those without an elective intraaortic balloon 
pump. However, when the five patients in whom the lesion 
could not be crossed with a guide wire are included, the 
procedural success rate for both groups combined was slightly 
lower than previous reports at 89%. This somewhat lower rate 
may reflect the complexity of lesions in the patients in the 
current study. In no patient with an elective intraaortic balloon 
pump were we unable to cross the lesion with a guide wire. 
Procedure-related hypotension and combined outcome. 
The occurrence of procedure-related systolic hypotension was 
equal in both groups. Systolic pressure decreased to 
<90 mm Hg in three (11%) and nine (7%) patients in Groups 
1 and 2, respectively and necessitated mergency intraaortic 
balloon pump placement infive Group 2 patients. In no patient 
who received an elective intraaortic balloon pump was diastolic 
pressure allowed to decrease <90 mm Hg, thus maintaining 
coronary perfusion. Multivariate analysis of the combined end 
point demonstrated that in light of all the preprocedural 
patient risk factors and lesion characteristics, placement of an 
intraaortic balloon pump prophylactically was the single most 
important factor associated with a more favorable procedural 
outcome. 
Slow flow and effect of intraaortic balloon pump on inci- 
dence of non-Q wave myocardial infarction after slow flow. In 
the current study we observed slow flow in the target artery 
with equal frequency in both groups. Published reports (4) 
have documented slow flow during rotational atherectomy in 
9% of procedures. In our patients, slow flow occurred with 
almost wice the frequency of that observed by Ellis et al. (4). 
This difference may be due in part to the inclusion in the latter 
study of patients with type A and B1 lesions, which have a 
lower risk of a complicated outcome. 
In the study by Ellis et al. (4), slow flow was associated with 
non-Q wave myocardial infarction in fully 25.9% of patients 
and with Q wave myocardial infarction in a further 7%. Among 
patients in the current study who did not have an elective 
intraaortic balloon pump, slow flow was followed by non-Q 
wave myocardial infarction in 27%. Despite asimilar incidence 
of slow flow, no patient with an elective intraaortic balloon 
pump developed a non-Q wave myocardial infarction. During 
rotational atherectomy, the release of microparticulate d bris 
and microcavitation within the epicardial coronary artery may 
contribute to slow flow (16,17). Recent studies have shown that 
intraaortic balloon pumping enhances coronary flow (18) and 
that a significant increase in coronary flow follows relief of 
obstructive stenosis by angioplasty, which is further augmented 
by intraaortic balloon pump counterpulsation (12). Thus, 
intraaortic balloon pumping appears to be effective in promot- 
ing diastolic perfusion and increasing coronary flow, thereby 
preventing the myocardial damage that accompanies slow flow. 
The salutary effect of intraaortic balloon pump counterpulsa- 
tion has also recently been shown (19) to promote patency of 
the infarct-related artery and to reduce recurrent ischemia 
rates after primary angioplasty for myocardial infarction. 
Vascular complications. Peripheral vascular complications 
and bleeding related to the intraaortic balloon pump have 
remained a major concern in trials evaluating supported 
percutaneous revascularization. I  one report (7), 3 (11%) of 
28 patients developed balloon pump-related complications 
requiring surgical intervention. A recent study (19) reported a
similar blood transfusion requirement among intraaortic bal- 
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loon pump recipients with no increase in vascular complica- 
tions needing surgical repair. In the present study, neither 
transfusion requirement or vascular complications were sig- 
nificantly higher among intraaortic balloon pump recipients 
than nonrecipients. These data suggest hat the benefit of 
intraaortic balloon pump support among high risk rotational 
atherectomy candidates may be achievable without an increase 
in adverse outcome or prolongation of hospital stay. 
Study limitations. Although these data are provocative 
and encouraging, several imitations must be acknowledged. 
This study suffers from all weaknesses inherent in retrospective 
data and, although the reduction in incidence of non-Q wave 
myocardial infarction after slow flow among elective intraaor- 
tic balloon pump recipients is intriguing, the data remain 
largely observational. The small number of patients in both 
groups and of study outcomes also limit our data. The difficulty 
with defining procedure-related hypotension i  two groups of 
patients with markedly different systemic pressures clearly 
weakens our ability to reach firm conclusions with regard to 
this variable. Further large randomized trials will be needed to 
confirm or refute our preliminary data. 
Conclusions. Prophylactic use of intraaortic balloon pump 
counterpulsation among high risk patients undergoing coro- 
nary rotational atherectomy contributes to an uncomplicated 
and successful outcome. If patients are carefully selected for 
intraaortic balloon pump support on the basis of angiographic 
characteristics, the outcome for a high risk group is as good as, 
and perhaps better than, that of a lower risk group. That this 
benefit can be achieved without an increase in duration of 
hospital stay or balloon pump-related complications suggests a 
new role for this familiar technology. 
We acknowledge the help of Kim Contreras in typing the manuscript and Jean 
Chart, MS for preparing the statistical analysis. 
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